Vo K - Search Results

1

Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.

Philipp J, Vo K, Gurley KE, Seidel K, Kemp CJ. Philipp J, et al. Among authors: vo k. Oncogene. 1999 Aug 19;18(33):4689-98. doi: 10.1038/sj.onc.1202840. Oncogene. 1999. PMID: 10467416

2

DNA double-strand breaks, p53, and apoptosis during lymphomagenesis in scid/scid mice.

Gurley KE, Vo K, Kemp CJ. Gurley KE, et al. Among authors: vo k. Cancer Res. 1998 Jul 15;58(14):3111-5. Cancer Res. 1998. PMID: 9679979

3

Resistance to skin tumorigenesis in DNAPK-deficient SCID mice is not due to immunodeficiency but results from hypersensitivity to TPA-induced apoptosis.

Kemp CJ, Vo K, Gurley KE. Kemp CJ, et al. Among authors: vo k. Carcinogenesis. 1999 Nov;20(11):2051-6. doi: 10.1093/carcin/20.11.2051. Carcinogenesis. 1999. PMID: 10545405

4

Bryostatin 1 acts synergistically with interleukin-1 alpha to induce secretion of G-CSF and other cytokines from marrow stromal cells.

Lilly M, Vo K, Le T, Takahashi G. Lilly M, et al. Among authors: vo k. Exp Hematol. 1996 Apr;24(5):613-21. Exp Hematol. 1996. PMID: 8605966

5

Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.

Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG. Vo KT, et al. Clin Cancer Res. 2016 Jul 15;22(14):3643-50. doi: 10.1158/1078-0432.CCR-15-2516. Epub 2016 Feb 9. Clin Cancer Res. 2016. PMID: 26861456 Free PMC article.

6

Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.

Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG. Vo KT, et al. J Clin Oncol. 2014 Oct 1;32(28):3169-76. doi: 10.1200/JCO.2014.56.1621. Epub 2014 Aug 25. J Clin Oncol. 2014. PMID: 25154816 Free PMC article.

7

Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma.

Davenport JR, Vo KT, Goldsby R, West DC, DuBois SG. Davenport JR, et al. Pediatr Blood Cancer. 2016 Jun;63(6):1091-5. doi: 10.1002/pbc.25945. Epub 2016 Feb 17. Pediatr Blood Cancer. 2016. PMID: 26891183

8

Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma.

Vo KT, Matthay KK, DuBois SG. Vo KT, et al. Clin Sarcoma Res. 2016 Jun 7;6:9. doi: 10.1186/s13569-016-0049-z. eCollection 2016. Clin Sarcoma Res. 2016. PMID: 27274393 Free PMC article. Review.

9

Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine.

Huibregtse KE, Vo KT, DuBois SG, Fetzko S, Neuhaus J, Batra V, Maris JM, Weiss B, Marachelian A, Yanik GA, Matthay KK. Huibregtse KE, et al. Among authors: vo kt. Eur J Cancer. 2016 Oct;66:144-52. doi: 10.1016/j.ejca.2016.07.017. Epub 2016 Aug 27. Eur J Cancer. 2016. PMID: 27573428 Free PMC article. Clinical Trial.

10

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors.

Vo KT, Karski EE, Nasholm NM, Allen S, Hollinger F, Gustafson WC, Long-Boyle JR, Shiboski S, Matthay KK, DuBois SG. Vo KT, et al. Oncotarget. 2017 Apr 4;8(14):23851-23861. doi: 10.18632/oncotarget.12904. Oncotarget. 2017. PMID: 27793021 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

342 results

Search Page